The company is developing a non-pharmaceutical treatment approach for cancer, inflammatory diseases, and autoimmune diseases with a blood-filtering device that has the potential to treat a wide variety of cancer types, including those that have not responded to other treatments. This treatment has the potential to reduce side effects, enhance therapy response rates, and improve cancer patients' quality of life, all at significantly lower costs than existing immunotherapy approaches. Immunicom's cancer therapy could allow the body's natural immune system to directly attack cancer while enhancing the effects of other cancer treatments used concurrently, reimagining how healing should be.